Page 59 - CW E-Magazine (Oct-Nov-2023)

Happenings

Aurigene Pharmaceutical approval from Chinese regulators,” he Caplin Point to set up step-
Services to invest Rs. said. down subsidiary to focus
330-crore in Hyderabad Aurobindo has lined up commis- on US market
sioning of three plants, including the
Aurigene Pharmaceutical Services,
a step-down subsidiary of Dr. Reddy’s one in China. A part of its US Raleigh Caplin Steriles Ltd., a subsidiary of
Laboratories, will invest Rs. 330-crore facility was commissioned in March Chennai-based Caplin Point Laborato-
in a development and manufacturing and the remaining is expected to get ries Ltd., said its board has approved
facility in the Genome Valley, Hyder- commissioned in due course. The Vizag setting up of a wholly-owned subsid-
abad, with a focus on niche areas such facility of its subsidiary, Lyfius Pharma, iary in the US.
as therapeutic proteins, antibodies and which will produce Pen-G, is expected
viral vectors. to be commissioned by the end of 2023. In a regulatory filing, the company
said the step-down subsidiary, Caplin
Corning and SGD Pharma Steriles USA Inc, will be based in Dela-
to open new glass tubing ware, and is expected to have an initial
facility in Telangana share capital of $500,000.

Caplin Point Laboratories caters
US-headquartered Corning Incor- predominantly to the emerging mar-
porated and French firm, SGD Pharma, kets of Latin America and Africa,
have announced a joint venture that while its wholly-owned subsidiary
includes the opening of a new pharma- Caplin Steriles Ltd., caters to regu-
ceutical glass tubing facility in Vemula, lated markets such as the US and Eu-
Aurigene plans to collaborate with Telangana.
the world’s leading biotech innovators rope, for injectable and ophthalmic
to facilitate the development and intro- Combining SGD Pharma’s vial- products. “The proposed step-down
duction of innovative medicines into the converting expertise with Corning’s subsidiary would be the front-end en-
tity for Caplin Steriles Ltd in the US
market. By leveraging their expertise proprietary glass-coating technology,
and resources, Aurigene aspires to con- the collaboration will enhance vial for direct sales, marketing and distri-
tribute to the advancement of healthcare quality, improve filling-line productiv- bution of products manufactured by
Caplin Steriles Ltd,” the company
by bringing cutting-edge treatments to ity, and speed the global delivery of in-
patients. jectable treatments. added.

Aurigene also has plans to expand Manufacturing of Velocity Vials at The proposed company would be
the facility by venturing into novel thera- SGD Pharma’s facility in Vemula is a wholly-owned subsidiary of Caplin
pies, particularly cell and gene therapies. expected to begin in 2024. Pharmaceu- Steriles Ltd., which is in turn a 99.99%
subsidiary of Caplin Point Laborato-
Aurobindo Pharma tical tubing production is expected to ries.
begin in 2025.
completes plant
installation in China Granules opens packaging
facility in Virginia
Hyderabad-based Aurobindo Phar-
ma has completed the installation of Pharmaceutical company, Gran-
its plant in China and is planning to ules India Ltd. has opened a packag-
commission it in the first quarter of ing facility in Virginia State of the US
FY2024-25, said Mr. Santhanam Sub- to expand the packaging capacity of
ramanian, Chief Financial Officer of essential drugs and strengthening its
the company. biopharma supply chain. The company

“We will be filing around five prod- has invested more than $100-mn in the
ucts from the China plant and will start country, said Dr. Krishna Prasad Chigu-
with the European despatches because rupati, Founder, Chairman and Manag-
it takes quite a lot of time to get the ing Director.

Chemical Weekly October / November 2023 55